Cellular MR Imaging

Cellular MR imaging is a young field that aims to visualize targeted cells in living organisms. In order to provide a different signal intensity of the targeted cell, they are either labeled with MR contrast agents in vivo or prelabeled in vitro. Either (ultrasmall) superparamagnetic iron oxide [(U)SPIO] particles or (polymeric) paramagnetic chelates can be used for this purpose. For in vivo cellular labeling, Gd3+- and Mn2+- chelates have mainly been used for targeted hepatobiliary imaging, and (U)SPIO-based cellular imaging has been focused on imaging of macrophage activity. Several of these magneto-pharmaceuticals have been FDA-approved or are in late-phase clinical trials. As for prelabeling of cells in vitro, a challenge has been to induce a sufficient uptake of contrast agents into nonphagocytic cells, without affecting normal cellular function. It appears that this issue has now largely been resolved, leading to an active research on monitoring the cellular biodistribution in vivo following transplantation or transfusion of these cells, including cell migration and trafficking. New applications of cellular MR imaging will be directed, for instance, towards our understanding of hematopoietic (immune) cell trafficking and of novel guided (stem) cell-based therapies aimed to be translated to the clinic in the future.

[1]  V. Runge,et al.  Safety of approved MR contrast media for intravenous injection , 2000, Journal of magnetic resonance imaging : JMRI.

[2]  A. Meunier,et al.  In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. , 2001, Journal of biomedical materials research.

[3]  Alan P Koretsky,et al.  Sizing it up: Cellular MRI using micron‐sized iron oxide particles , 2005, Magnetic resonance in medicine.

[4]  M. Rausch,et al.  In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO , 2002, NMR in biomedicine.

[5]  J. Baker,et al.  Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[7]  Roland Martin,et al.  Magnetic resonance imaging of labeled T‐cells in a mouse model of multiple sclerosis , 2004, Annals of neurology.

[8]  P. Marzullo.  Nuclear imaging after cell implantation. , 2004, International journal of cardiology.

[9]  Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  E T Ahrens,et al.  Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging , 2003, Magnetic resonance in medicine.

[11]  Trevor Douglas,et al.  MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain , 2003, Magnetic resonance in medicine.

[12]  Scott E. Fraser,et al.  Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study , 2004, NeuroImage.

[13]  M. Verhoye,et al.  In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system , 2002, Neuroscience.

[14]  R. Weissleder,et al.  Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.

[15]  J. Frangioni,et al.  In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease , 2004, Circulation.

[16]  Aaron J. Johnson,et al.  In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  H. Blau,et al.  In vivo monitoring of myoblast transplantation into rat myocardium. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  J. Debus,et al.  CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm. , 2002, Cancer research.

[19]  Bartley P. Griffith,et al.  Macrophage Accumulation Associated With Rat Cardiac Allograft Rejection Detected by Magnetic Resonance Imaging With Ultrasmall Superparamagnetic Iron Oxide Particles , 2001, Circulation.

[20]  D. Baumann,et al.  Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation , 2003, Magnetic Resonance in Medicine.

[21]  J. Lee,et al.  Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. , 1994, Magnetic resonance imaging.

[22]  J. Bulte,et al.  Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry. , 1996, Academic radiology.

[23]  Jeff W M Bulte,et al.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.

[24]  R. Weissleder,et al.  Human transferrin receptor gene as a marker gene for MR imaging. , 2001, Radiology.

[25]  M. Rausch,et al.  Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage , 2001, Magnetic resonance in medicine.

[26]  J. Bacri,et al.  Interaction of Anionic Superparamagnetic Nanoparticles with Cells: Kinetic Analyses of Membrane Adsorption and Subsequent Internalization , 2002 .

[27]  D L Kent,et al.  MR contrast media in neuroimaging: a critical review of the literature. , 1999, AJNR. American journal of neuroradiology.

[28]  Fan Wang,et al.  Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord , 2004, Neuroreport.

[29]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[30]  J. Bulte,et al.  DENDRIMERS: Chemical principles and biotechnology applications , 2001 .

[31]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[32]  E. Rummeny,et al.  In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging , 2004, European Radiology.

[33]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[34]  D. Farkas,et al.  Optical Imaging of PKH‐Labeled Hematopoietic Cells in Recipient Bone Marrow In Vivo , 2002, Stem cells.

[35]  E. Rummeny,et al.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. , 2005, Radiology.

[36]  H. Shinohara,et al.  Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. , 2001, Bioconjugate chemistry.

[37]  Alan P. Koretsky,et al.  Tracing Odor-Induced Activation in the Olfactory Bulbs of Mice Using Manganese-Enhanced Magnetic Resonance Imaging , 2002, NeuroImage.

[38]  Matthew J Dalby,et al.  The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. , 2004, International journal of pharmaceutics.

[39]  Mathias Hoehn,et al.  Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Mintorovitch,et al.  Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. , 1993, Radiology.

[41]  C. Combe,et al.  Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. , 2000, Radiology.

[42]  Myeong-Jin Kim,et al.  Detection and characterization of focal hepatic lesions: Mangafodipir vs. Superparamagnetic iron oxide‐enhanced magnetic resonance imaging , 2004, Journal of magnetic resonance imaging : JMRI.

[43]  P. Meier,et al.  Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.

[44]  M. Rausch,et al.  Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide‐enhanced magnetic resonance imaging , 2004, Journal of magnetic resonance imaging : JMRI.

[45]  Elliot R. McVeigh,et al.  Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.

[46]  H. Anthonsen,et al.  Intracellular manganese ions provide strong T1 relaxation in rat myocardium , 2004, Magnetic resonance in medicine.

[47]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[48]  S. Williams,et al.  Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats. , 1996, AJNR. American journal of neuroradiology.

[49]  J. Lloyd,et al.  Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. , 1986, Biochimica et biophysica acta.

[50]  Phantom and animal studies of a new hepatobiliary agent for MR imaging: Comparison of Gd‐DTPA‐DeA with Gd‐EOB‐DTPA , 2003, Journal of magnetic resonance imaging : JMRI.

[51]  B R Rosen,et al.  Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. , 1999, Neuroreport.

[52]  M Chopp,et al.  Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum , 2003, Neuroscience.

[53]  Jeff W M Bulte,et al.  Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. , 2004, Blood.

[54]  R. Pautler.  In vivo, trans‐synaptic tract‐tracing utilizing manganese‐enhanced magnetic resonance imaging (MEMRI) , 2004, NMR in biomedicine.

[55]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[56]  Jérôme Garot,et al.  Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. , 2003, Journal of the American College of Cardiology.

[57]  Trevor Douglas,et al.  In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord , 2004, Experimental Neurology.

[58]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[59]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[60]  B Hamm,et al.  Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles , 2001, Journal of magnetic resonance imaging : JMRI.

[61]  Mathias Hoehn,et al.  Improved Stem Cell MR Detectability in Animal Models by Modification of the Inhalation Gas , 2005, Molecular imaging.

[62]  Bradley D. Smith,et al.  High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. , 2000, Bioconjugate chemistry.

[63]  Ralph Weissleder,et al.  Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.

[64]  J. Bacri,et al.  Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.

[65]  R. Weissleder,et al.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.

[66]  Luigi Biancone,et al.  Improved route for the visualization of stem cells labeled with a Gd‐/Eu‐Chelate as dual (MRI and fluorescence) agent , 2004, Magnetic resonance in medicine.

[67]  R. Weissleder,et al.  Preclinical assessment of hepatocyte‐targeted MR contrast agents in stable human liver cell cultures , 1998, Journal of magnetic resonance imaging : JMRI.

[68]  B. Byrne,et al.  Noninvasive Monitoring and Tracking of Muscle Stem Cell Transplants , 2004, Transplantation.

[69]  W. Shen,et al.  Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Chien Ho,et al.  Intracellular labeling of T‐cells with superparamagnetic contrast agents , 1993, Magnetic resonance in medicine.

[71]  J. Bulte,et al.  Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. , 2001, Journal of the American Chemical Society.

[72]  J. Bulte,et al.  MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. , 2006, Radiology.

[73]  Y Zhang,et al.  Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. , 2000, Kidney international.

[74]  S. Fraser,et al.  Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. , 1995, Chemistry & biology.

[75]  Steven C. R. Williams,et al.  In vivo monitoring of cellular transplants by magnetic resonance imaging and positron emission tomography , 2004, Expert opinion on biological therapy.

[76]  J. Bulte,et al.  Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. , 2004, Methods in enzymology.

[77]  Sanjiv S Gambhir,et al.  Quantitative imaging of the T cell antitumor response by positron-emission tomography , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Rausch,et al.  MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE , 2003, Magnetic resonance in medicine.

[79]  Ralph Weissleder,et al.  In vivo tracking of neural progenitor cell migration to glioblastomas. , 2003, Human gene therapy.

[80]  Martin Bendszus,et al.  in Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[81]  M. Naghavi,et al.  Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-&agr;, Interleukin-1&bgr;, and Interferon-&ggr; , 2003, Circulation.

[82]  Mariano G. Uberti,et al.  Tracking superparamagnetic iron oxide labeled monocytes in brain by high‐field magnetic resonance imaging , 2003, Journal of neuroscience research.

[83]  S. Larson,et al.  Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. , 2001, Cancer research.

[84]  U. Mahmood.  Can MR imaging be used to track delivery of intravascularly administered stem cells? , 2004, Radiology.

[85]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[86]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[87]  F. Lazeyras,et al.  Specificity of SPIO particles for characterization of liver hemangiomas using MRI , 2003, Abdominal Imaging.

[88]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[89]  B Quesson,et al.  In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance , 1999, Magnetic resonance in medicine.

[90]  Ernst J. Rummeny,et al.  Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[91]  C. Contag,et al.  Bioluminescence imaging of lymphocyte trafficking in vivo. , 2001, Experimental hematology.

[92]  Scott E. Fraser,et al.  Tracking Transplanted Stem Cell Migration Using Bifunctional, Contrast Agent-Enhanced, Magnetic Resonance Imaging , 2002, NeuroImage.

[93]  Enzo Terreno,et al.  Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.

[94]  Anna Devor,et al.  In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing , 2003, NeuroImage.

[95]  Michel Sadelain,et al.  Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes , 2003, Nature Biotechnology.

[96]  W. Rogers,et al.  Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. , 2005, Atherosclerosis.

[97]  R Weissleder,et al.  Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. , 2000, Bioconjugate chemistry.

[98]  J. Bulte,et al.  Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. , 2002, Academic radiology.

[99]  Jeff W. M. Bulte,et al.  Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites , 2001 .

[100]  R E Jacobs,et al.  Fluorescently detectable magnetic resonance imaging agents. , 1998, Bioconjugate chemistry.

[101]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[102]  Fan Wang,et al.  In vivo tracking of implanted stem cells using radio-labeled transferrin scintigraphy. , 2004, Nuclear medicine and biology.

[103]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[104]  J. Bulte,et al.  Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation , 1998, Journal of Neuroscience Research.

[105]  D. Fox,et al.  Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantation. , 1999, The Journal of surgical research.

[106]  R Weissleder,et al.  Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. , 1991, Radiology.

[107]  E. Groman,et al.  Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex dose in rats. , 1998, Magnetic Resonance Imaging.

[108]  Ralph Weissleder,et al.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.

[109]  M. Fukunaga,et al.  Dynamic activity‐induced manganese‐dependent contrast magnetic resonance imaging (DAIM MRI) , 2002, Magnetic resonance in medicine.

[110]  R E Jacobs,et al.  Magnetic resonance microscopy of embryonic cell lineages and movements. , 1994, Science.

[111]  Nathalie Siauve,et al.  Liver Imaging With Ferumoxides (Feridex®): Fundamentals, Controversies, and Practical Aspects , 1998, Topics in magnetic resonance imaging : TMRI.

[112]  R. Franklin,et al.  Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. , 1999, Neuroreport.

[113]  B. Griffith,et al.  A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. , 2000, The Journal of thoracic and cardiovascular surgery.

[114]  M. Aschner,et al.  Manganese Neurotoxicity , 2004, Annals of the New York Academy of Sciences.

[115]  T. Meade,et al.  Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. , 2003, Nuclear Medicine and Biology.

[116]  Thomas J. Meade,et al.  Synthesis and visualization of a membrane-permeable MRI contrast agent , 2003, JBIC Journal of Biological Inorganic Chemistry.

[117]  M. Rovaris,et al.  Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. , 1999, Magnetic resonance imaging.

[118]  Mathias Hoehn,et al.  MRI detection of macrophage activity after experimental stroke in rats: New indicators for late appearance of vascular degradation? , 2005, Magnetic resonance in medicine.

[119]  J. Bulte,et al.  Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.

[120]  J Bittoun,et al.  Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging , 2003, Magnetic resonance in medicine.

[121]  C. Contag,et al.  Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 , 2001, The Journal of Immunology.

[122]  Mangay Williams,et al.  Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability , 2003, Transplantation.

[123]  U. Heinzmann,et al.  Highly efficient paramagnetic labelling of embryonic and neuronal stem cells , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[124]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[125]  C. Combe,et al.  MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome , 1999, Magnetic resonance in medicine.

[126]  P. Reimer,et al.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.

[127]  R E Jacobs,et al.  Looking deeper into vertebrate development. , 1999, Trends in cell biology.

[128]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[129]  Alan P Koretsky,et al.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.

[130]  Andras Lakatos,et al.  Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS , 2004, The Journal of Neuroscience.

[131]  Peter C M van Zijl,et al.  Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer‐poly(rU) model for nucleic acid delivery and pharmacology , 2003, Magnetic resonance in medicine.

[132]  Peter J. Donovan,et al.  Derivation of pluripotent stem cells from cultured human primordial germ cells , 1998 .

[133]  L. Macarini,et al.  Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis. , 2004, La Radiologia medica.

[134]  T. Meade,et al.  Cellular delivery of MRI contrast agents. , 2004, Chemistry & biology.

[135]  Aaron J. Johnson,et al.  Magnetic resonance imaging of immune cells in inflammation of central nervous system. , 2003, Croatian medical journal.

[136]  Nicolas Grenier,et al.  In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. , 2004, Radiology.

[137]  J. Bacri,et al.  Deformation of intracellular endosomes under a magnetic field , 2003, European Biophysics Journal.

[138]  Rika Takikawa,et al.  [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[139]  Ralph Weissleder,et al.  Imaging of Stem Cell Recruitment to Ischemic Infarcts in a Murine Model , 2004, Stroke.

[140]  R. Weissleder,et al.  Methotrexate-Induced Accumulation of Fluorescent Annexin V in Collagen-Induced Arthritis , 2005, Molecular imaging.

[141]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[142]  Doris A Taylor,et al.  Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.

[143]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R Weissleder,et al.  MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.

[145]  G. Gores,et al.  Diagnosis and staging of hepatocellular carcinoma. , 2004, Gastroenterology.

[146]  E de Kerviler,et al.  Contrast agents in magnetic resonance imaging of the liver: present and future. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[147]  C. Contag,et al.  Advances in in vivo bioluminescence imaging of gene expression. , 2002, Annual review of biomedical engineering.

[148]  Jeff W M Bulte,et al.  Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis , 2004, NMR in biomedicine.

[149]  H. Fine,et al.  Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. , 2005, Blood.

[150]  Ulrich Heinzmann,et al.  Targeting of hematopoietic progenitor cells with MR contrast agents. , 2003, Radiology.

[151]  Mathias Hoehn,et al.  Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia , 2004, Magnetic resonance in medicine.

[152]  R. Weissleder.  Liver MR imaging with iron oxides: toward consensus and clinical practice. , 1994, Radiology.

[153]  R. Wahl,et al.  111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction , 2003, Nuclear medicine communications.

[154]  Andreas Saleh,et al.  In vivo MRI of brain in ̄ ammation in human ischaemic stroke , 2004 .

[155]  Deborah Burstein,et al.  In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction , 2004, Magnetic resonance in medicine.

[156]  B. Palsson,et al.  Phototoxicity of the fluorescent membrane dyes PKH2 and PKH26 on the human hematopoietic KG1a progenitor cell line. , 1999, Cytometry.

[157]  G. Liu,et al.  Evaluation of [Gd(Bz‐TTDA)]2– as a potential contrast agent in MR imaging of the hepatobiliary system: An animal study , 2004, Journal of magnetic resonance imaging : JMRI.

[158]  Eva Syková,et al.  Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles , 2003, Magnetic resonance in medicine.

[159]  C Delalande,et al.  Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. , 1999, AJNR. American journal of neuroradiology.

[160]  R. Brasch,et al.  Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. , 1992, Investigative radiology.

[161]  Dynamic liver imaging with iron oxide agents: Effects of size and biodistribution on contrast , 1997, Magnetic resonance in medicine.

[162]  J. Babb,et al.  Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. , 2004, Radiology.

[163]  J. Bulte,et al.  Noninvasive monitoring of stem cell transfer for muscle disorders , 2004, Magnetic Resonance in Medicine.

[164]  Michael Chopp,et al.  In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor , 2004, NeuroImage.

[165]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[166]  P. Carlier,et al.  Assessing gene and cell therapies applied in striated skeletal and cardiac muscle: Is there a role for nuclear magnetic resonance? , 2003, Neuromuscular Disorders.

[167]  Eliana Gianolio,et al.  Insights into the use of paramagnetic Gd(III) complexes in MR‐molecular imaging investigations , 2002, Journal of magnetic resonance imaging : JMRI.

[168]  H. Ichikawa,et al.  In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[169]  B. Rice,et al.  In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.

[170]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[171]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[172]  Michael Chopp,et al.  Magnetic resonance imaging and neurosphere therapy of stroke in rat , 2003, Annals of neurology.

[173]  S. Gambhir,et al.  Molecular Imaging of Cardiac Cell Transplantation in Living Animals Using Optical Bioluminescence and Positron Emission Tomography , 2003, Circulation.

[174]  N. Beckmann,et al.  Macrophage infiltration into the rat knee detected by MRI in a model of antigen‐induced arthritis , 2003, Magnetic resonance in medicine.

[175]  J A Frank,et al.  Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition , 2003, Magnetic resonance in medicine.

[176]  W. Oyen,et al.  MR tracking of magnetically-labeled dendritic cells migrating to lymph nodes in melanoma patients: First clinical experience , 2005 .